63 related articles for article (PubMed ID: 2677169)
1. [Immunohistochemical study on the MHC class I antigen expression on squamous cell carcinoma of the uterine cervix].
Honma S; Nakamura M; Maruhashi T; Kodama S; Obata N; Kanazawa K; Takahashi T; Sasagawa S; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):813-8. PubMed ID: 2677169
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistological study on HLA class II antigen expression and lymphocyte infiltration in cancer tissues of the uterine cervix].
Nakamura M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):349-56. PubMed ID: 1607758
[TBL] [Abstract][Full Text] [Related]
3. [An immunohistochemical study on regional immunological response of uterine cervical cancer].
Okamoto Y
Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):456-62. PubMed ID: 2373918
[TBL] [Abstract][Full Text] [Related]
4. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
5. MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.
Andratschke M; Pauli C; Stein M; Chaubal S; Wollenberg B
Anticancer Res; 2003; 23(2B):1467-71. PubMed ID: 12820411
[TBL] [Abstract][Full Text] [Related]
6. Tissue evaluation of immune markers in endometrial and cervical carcinomas.
Lazaris ACh; Chatzigianni EB; Xidias G; Panoskaltsis TA; Thomopoulou GC; Eftychiadis CA; Michalas S; Patsouris ES
J Exp Clin Cancer Res; 2004 Jun; 23(2):269-75. PubMed ID: 15354412
[TBL] [Abstract][Full Text] [Related]
7. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
[TBL] [Abstract][Full Text] [Related]
8. MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression.
Cromme FV; Snijders PJ; van den Brule AJ; Kenemans P; Meijer CJ; Walboomers JM
Oncogene; 1993 Nov; 8(11):2969-75. PubMed ID: 8414499
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
Kloth JN; Gorter A; Fleuren GJ; Oosting J; Uljee S; ter Haar N; Dreef EJ; Kenter GG; Jordanova ES
J Pathol; 2008 Jul; 215(3):222-30. PubMed ID: 18438953
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
[TBL] [Abstract][Full Text] [Related]
11. [A study of the expression of class II antigen on uterine cervical cancer cells and cell lines].
Okamoto Y; Ueda M; Yamada T; Misaki O; Seiki Y; Tsurunaga T; Iwai E; Ueki M; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1819-25. PubMed ID: 2974857
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
Jordanova ES; Gorter A; Ayachi O; Prins F; Durrant LG; Kenter GG; van der Burg SH; Fleuren GJ
Clin Cancer Res; 2008 Apr; 14(7):2028-35. PubMed ID: 18381941
[TBL] [Abstract][Full Text] [Related]
13. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.
Ryu KS; Lee YS; Kim BK; Park YG; Kim YW; Hur SY; Kim TE; Kim IK; Kim JW
Exp Mol Med; 2001 Sep; 33(3):136-44. PubMed ID: 11642549
[TBL] [Abstract][Full Text] [Related]
14. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
15. Correlative light and immunohistological study of the HCG-like antigen in the squamous cell carcinoma of the human uterine cervix.
Yamasaki M; Ueda G; Inoue M; Tanaka Y; Tanizawa O; Kurachi K
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):151-4. PubMed ID: 7014735
[TBL] [Abstract][Full Text] [Related]
16. [Research into the human leucocyte antigen I deletion and local lymphocytes infiltration in laryngeal carcinoma].
Niu C; Liu X; Zhou W; Jing L; Du B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Jun; 37(3):215-8. PubMed ID: 12772327
[TBL] [Abstract][Full Text] [Related]
17. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
18. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
[TBL] [Abstract][Full Text] [Related]
19. Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma.
van Driel WJ; Tjiong MY; Hilders CG; Trimbos BJ; Fleuren GJ
Gynecol Oncol; 1996 Jul; 62(1):33-41. PubMed ID: 8690288
[TBL] [Abstract][Full Text] [Related]
20. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.
Ogino T; Bandoh N; Hayashi T; Miyokawa N; Harabuchi Y; Ferrone S
Clin Cancer Res; 2003 Sep; 9(11):4043-51. PubMed ID: 14519625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
